Professional Documents
Culture Documents
Four Days Session - Day 3 Updated - Presentation
Four Days Session - Day 3 Updated - Presentation
Dr. C. SHANMUGAPRIYA
FATTY ACID SYNTHESIS
FACTS ABOUT FATTY ACID SYNTHESIS
FACTS ABOUT FATTY ACID SYNTHESIS
• Cytoplasm
FACTS ABOUT FATTY ACID SYNTHESIS
• Cytoplasm
• Acetyl CoA is the building block
FACTS ABOUT FATTY ACID SYNTHESIS
• Cytoplasm
• Acetyl CoA is the building block
SOURCES OF ACETYL COA
malate
Prefffaffat
fyhnfA
OAA
TAtpunfp.ae
titrate
grit citate
FATES OF ACETYL COA
AUTEMREE
B
cholent
FACTS ABOUT FATTY ACID SYNTHESIS
• Cytoplasm
• Acetyl CoA is the building block
• Acetyl CoA carboxylase is the rate limiting enzyme
SWA oh swA
JCB f of
Biotin Maligned
Au Bicarb
ATP
FACTS ABOUT FATTY ACID SYNTHESIS
• Cytoplasm
• Acetyl CoA is the building block
• Acetyl CoA carboxylase is the rate limiting enzyme
• Fatty acid synthase complex is the other enzyme complex involved
FACTS ABOUT FATTY ACID SYNTHASE COMPLEX
Yoram 010
xp 910
7
00
THE
f
FACTS ABOUT FATTY ACID SYNTHASE COMPLEX
a
yyy gyy
yggg.gg pan MEECH cuz
co f
keoayesymayhpyen.ge rename
cys Gs 4
jan
Iffdffzketoaidpag m.mg
ffm
STEPS OF FATTY ACID SYNTHESIS
eye
In 9fEI24
adS
ianT
palmitic
STEPS OF FATTY ACID SYNTHESIS
2C
CoA
acetyl malefwa
1 2 NADPH
1 malonyl
CoA 2
Chf 1 ATPs
coa 12
acetyl
SUBUNITS OF FATTY ACID SYNTHASE COMPLEX
acid 16
palmitic 7 ATP
1HNADPH
WA 7 malonylCoA
acetyl
ER Throatian
ATA MTA KAS KAR Mychal
Acp
SUBUNITS OF FATTY ACID SYNTHASE COMPLEX
• Acetyl Transacylase
• Malonyl Transacylase
• Ketoacyl Synthase
• Ketoacyl reductase
• Hydratase
• Enoyl reductase
• Thioestaerase
• Acyl Carrier protein
REGULATION OF ACETYL COA CARBOXYLASE
REGULATION OF ACETYL COA CARBOXYLASE
ATP
NADY
FADUZ
citrate
Invelli
REGULATION OF ACETYL COA CARBOXYLASE
• FADH2 ○ NAD
• Citrate
• Bgalactoridas
Insulin ○ FAD
○ Acyl CoA
Dagestan
S.No PATHWAY RATE LIMITING ENZYMES
RATE LIMITING ENZYME
fify
FA Synthein AcetylCoA Carbylene
2
Is odour carnitine
3
Acyltryman I
Cholutie Synher HMGCoA reductase
4
Bile acid Syntten 7 α hydroxylase
5
keleiebodyfyretehnacotly.ae Synttare
S.No PATHWAY RATE LIMITING ENZYMES
RATE LIMITING ENZYME
DHAP
Aly
Motioned
93p
Q3 – Lipogenesis is stimulated by all, EXCEPT :
a – High fatty diet
b – High Glucose diet
c – High Fructose based diet
d – Insulin
CHOLESTEROL SYNTHESIS
FACTS ABOUT CHOLESTEROL SYNTHESIS
PHASE I 2Acetylen
Thiolace
acettaught
acetyloot una cossynman
UMANA
NADPH UMANA reductase R E
mevalonate
PHASE II mevalonate
CO2
Isoprenoid unite
PHASE III 6 Isoprenoid
d Dohill
Ubiquinone
cytepter I
Hene A
Squalene
PHASE IV Squalue
Squale Encore
I ER
Lenoriot
PHASE V Lanoste
Zymo
Dorno
cholecter
REGULATION OF CHOLESTEROL SYNTHESIS
REGULATION OF HMG COA REDUCTASE
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
• Covalent Modification
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation Reloads
mevalonate Cholulet
• Covalent Modification
• Induction or Repression
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
• Inhibited by all its products
• Covalent Modification
• Induction or Repression
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
• Inhibited by all its products
• Mevalonate, Cholesterol and Bile acid
• Covalent Modification
• Induction or Repression
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
• Inhibited by all its products
• Mevalonate, Cholesterol and Bile acid
• Covalent Modification
• Dephosphorylation
• Induction or Repression
REGULATION OF HMG COA REDUCTASE
• Allosteric Regulation
• Inhibited by all its products
• Mevalonate, Cholesterol and Bile acid
• Covalent Modification
• Dephosphorylation
• Induction or Repression
• Insulin induces in adipose tissue
REGULATION BY REPRESSION
GREY
SREBP
of
Ñm
sr
CHOLESTEROL SYNTHESIS – FACTS
• Cholesterol synthesis takes place in
a. Cytoplasm
b. Nucleus
c. Endoplasmic reticulum
d. a & c
• Cholesterol synthesis takes place in
a. Cytoplasm
b. Nucleus
c. Endoplasmic reticulum
d. a & c
Q1 – Statins act by inhibiting:
a – HMG CoA reductase
b – HMG CoA Lyase
c – Acetyl CoA carboxylase
d – 7 alpha hydroxylase
Q1 – Statins act by inhibiting:
a – HMG CoA reductase
b – HMG CoA Lyase
c – Acetyl CoA carboxylase
d – 7 alpha hydroxylase
Q1 – All the following are byproducts of cholesterol
synthesis except:
a – Dolichol
b – Ubiquitin
c – Heme A
d – Cholesterol
Q1 – All the following are byproducts of cholesterol
synthesis except:
a – Dolichol
b – Ubiquitin
c – Heme A
d – Cholesterol
FATTY ACID OXIDATION
FATTY ACID OXIDATION – FEW FACTS
FATTY ACID OXIDATION – FEW FACTS
• Mitochondria
FATTY ACID OXIDATION
• Very Long chain fatty acids get oxidised in peroxisome
FATTY ACID OXIDATION
• Very Long chain fatty acids get oxidised in peroxisome
• Very short chain fatty acids get oxidised in mitochondria
FATTY ACID OXIDATION
• Very Long chain fatty acids get oxidised in peroxisome
• Very short chain fatty acids get oxidised in mitochondria
• Short chain, medium chain and long chain fatty acids get oxidised in
both mitochondria and peroxisome
FATTY ACID OXIDATION
• β oxidation
FATTY ACIDS β
• CH3–CH2–CH2–CH2–CH2-CH2–CH2–CH2–CH2–CH2-CH3–CH2–CH2–CH2–CH2–CH2–CH2-COOH
nwHnaÑf
DIFFERENCE BETWEEN MITOCHONDRIAL AND
PEROXISOMAL OXIDATION
S.No PROPERTY MITOCHONDRIA PEROXISOME
1 Type of fatty acids Very short, short, medium and Short, medium, long and very long chain
long chain fatty acid fatty acid
2 Type of oxidation β oxidation β oxidation
pop T.FI
AMPtPPi
Acycot
symeten
carnitine
88
pays
NCA
ygyif.IT
FATE OF A FATTY ACID IN A CELL
FATTY ACID
Acyl CoA
ATP à AMP synthetase
Acyl CoA
CPT1
TAG
β
Cholesterol OXIDATION
Acyl CoA
ester
Acetyl CoA
HIGH LOW
ENERGY ENERGY
PHASES OF FATTY ACID OXIDATION
myfayot.pt
INCFA
I
t
02
Coz
10ATPO
PHASES OF FATTY ACID OXIDATION
• Phase I: n C fatty acids à n/2 acetyl CoA
PHASES OF FATTY ACID OXIDATION
• Phase I: n C fatty acids à n/2 acetyl CoA
• Phase II: Acetyl CoA gets into TCA cycle
STEPS OF BETA OXIDATION OF FATTY ACIDS
R Apr CoA
2 quSWA Acyl
CoAdehydrogenase
FATTY
1 EATRERADU Acyl
β mahatma
off foot
WHIP R
Yp Y
Hychatare
qNJ
COA β hycheryacyloot
2 FATEHLET BHAGWAdehydrogenase
f f
keoacylcot tw
uesAcelifecoA
o
STEPS OF BETA OXIDATION OF FATTY ACIDS
DETAILS OF PHASE I – EVERY CYCLE D
ENZYMES INVOLVED ENERGETICS PRODUCT
hydrator AcetylCoA
BUAC delychogue NADH 2 KATPS 2C
Thiolone
4 ATPS
DETAILS OF PHASE I – EVERY CYCLE
ENZYMES INVOLVED ENERGETICS PRODUCT
Hydratase
Thiolase
ENERGETICS OF BETA OXIDATION OF FATTY ACIDS
II
10 2
1 1 4 EX
ENERGETICS OF BETA OXIDATION OF FATTY ACIDS
10
1
1 4 2 2
1 1 4 8 40
80 2
28
1060
REGULATION OF CPT1
REGULATION OF CPT1
• STIMULATORS
REGULATION OF CPT1
• STIMULATORS ● INHIBITORS
WIFI M1A
NAD
FAD
Glucign
AcylevA
REGULATION OF CPT1
• STIMULATORS ● INHIBITORS
ii
• ADP
ATP
• NAD
• FAD FADUZ
• Glucagon Inulin
• Acyl CoA
yfA
y
E
FAsymi.TL Matron
REGULATION OF CPT1
• STIMULATORS ● INHIBITORS
• ADP ● ATP
• NAD ● NADH
● FADH2
• FAD
● Insulin
• Glucagon ● Malonyl CoA
• Acyl CoA
METABOLIC CHANGES IN DKA
www
Pgluxz
i
ii
e
METABOLIC CHANGES IN STARVATION
STEPS INVOLVED IN KETONE BODY SYNTHESIS
2Acetyler
Thiolan
acetoaeeytw acelje
funawtsynt
u
C.in acetoacetate
pursued
FACTS ABOUT KETONE BODY METABOLISM
FACTS ABOUT KETONE BODY METABOLISM
• Ketone bodies are products of incomplete fatty acid oxidation
• They are synthesised in diabetes and starvation because of low
availability of oxaloacetate
• Ketone bodies are synthesised in liver mitochondria
• Ketone bodies are utilised by extrahepatic tissues
• Liver can not utilise ketone bodies because they lack thiophorase or
succinyl CoA acetoacetate coA transferase
BIOCHEMICAL FEATURES OF FATTY ACID OXIDATION DEFECTS
Hypoglycemia FAO2
Non
keloticlynogeycemi FAcey.eu
LUNG
FA0 AA02 NHz
298kchemo
Decanguinidine
BIOCHEMICAL FEATURES OF FATTY ACID OXIDATION DEFECTS
Dente Acquired
CATI
CATII Tamydipeddtime
ACD Misalpitddishier
Hydrant
BUALD
Tholeie
BIOCHEMICAL FEATURES OF FATTY ACID OXIDATION DEFECTS
• Hyperammonemia
• Dicarboxylic aciduria
ODD CHAIN FATTY ACID OXIDATION
Bovidalefs august 2th
ICFA
f acelytotffs
coA
3 FA Propinje
0
propionylCoA
Pc caryear
DmanyemalonylCoA
MM Racemare
MCQs Monytaratomi
Tenengmabyent acidimie
Adenyl Biz 11 MMM
of Badefania
Sueytwa
B12defining MMA Afli
an overjhe
fact
Q1 – Fatty acid Oxidation occurs in:
a – Mitochondria
b – Peroxisome
c – Both
d – None
Q1 – Fatty acid Oxidation occurs in:
a – Mitochondria
b – Peroxisome
c – Both
d – None
Q2 – Very short chain fatty acid Oxidation occurs in:
a – Mitochondria
b – Peroxisome
c – Both
d – None
Q2 – Very short chain fatty acid Oxidation occurs in:
a – Mitochondria
b – Peroxisome
c – Both
d – None
Q3 – Very long chain fatty acids undergo
a – β Oxidation
b – ω Oxidation
c – α Oxidation
d – γ Oxidation
Q3 – Very long chain fatty acids undergo
a – β Oxidation
b – ω Oxidation
c – α Oxidation
d – γ Oxidation
Q4 – Rate limiting enzyme of fatty acid oxidation:
a – Carnitine Acyl Transferase I
b – Carnitine Acyl Transferase II
c – Acyl CoA dehydrogenase
d – Thiolase
Q4 – Rate limiting enzyme of fatty acid oxidation:
a – Carnitine Acyl Transferase I
b – Carnitine Acyl Transferase II
c – Acyl CoA dehydrogenase
d – Thiolase
Q5 – How many cycles of beta oxidation does Palmitic
acid go through :
a–7
b–8
c–9
d – 16
Q5 – How many cycles of beta oxidation does Palmitic
acid go through :
a–7
b–8
c–9
d – 16
Q1 – CPT1 is activated by all, EXCEPT:
NEET
a – Acyl CoA
b – Malonyl CoA
c – High ADP/ATP ratio
d – Glucagon
Q1 – CPT1 is activated by all, EXCEPT:
a – Acyl CoA
b – Malonyl CoA
c – High ADP/ATP ratio
d – Glucagon
Q2 – Number of ATP generated in the liver by
complete oxidation of Palmitate:
a – 106
b – 33
c – 26
d – 16
Q2 – Number of ATP generated in the liver by
complete oxidation of Palmitate:
a – 106
b – 33
c – 26
d – 16
Q3 – Number of ATP generated in the liver by
complete oxidation of Stearic acid is:
a – 106
b – 120
c – 30
d – 26
Q3 – Number of ATP generated in the liver by
complete oxidation of Stearic acid is:
a – 106
b – 120
c – 30
d – 26
ketosis is observed in Diabetes because of:
a – Low availability of oxaloacetate
b – Excess oxaloacetate
c – Low energy
d – Low fatty acid oxidation
ketosis is observed in Diabetes because of:
a – Low availability of oxaloacetate
b – Excess oxaloacetate
c – Low energy
d – Low fatty acid oxidation
Liver can not utilize ketone bodies because of lack
of:
a – Thiolase
b – Thioesterase
c – Thiophorase
d – Aconitase
Liver can not utilize ketone bodies because of lack
of:
a – Thiolase
b – Thioesterase
c – Thiophorase
d – Aconitase
Fatty acid oxidation defects present with all except:
a – Hypoglycemia
b – ketosis
c – Hyperammonemia
d – Dicarboxylic aciduria
Fatty acid oxidation defects present with all except:
a – Hypoglycemia
b – ketosis
c – Hyperammonemia
d – Dicarboxylic aciduria
HYPERLIPOPROTEINEMIAS
HYPERLIPOPROTEINEMIAS
• Friedrickson’s Classification
HYPERLIPOPROTEINEMIAS
• Friedrickson’s Classification
• Six types
HYPERLIPOPROTEINEMIAS
• Friedrickson’s Classification
• Six types
• Type I
• Type IIa
• Type IIb
• Type III
• Type IV
• Type V
HYPERLIPOPROTEINEMIAS
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia
• Hypertriglyceridemia
HYPERLIPOPROTEINEMIAS
annomas
• Hypercholesterolemia Tenden
atheoselem
ace
• Hypertriglyceridemia
• Both
HYPERLIPOPROTEINEMIAS
Tendon Xanthomas
• Hypercholesterolemia Accelerated
atherosclerosis
• Hypertriglyceridemia
• Both
0000000
0 0
TENDON
XANTHOMAS
HYPERLIPOPROTEINEMIAS
Tendon Xanthomas
• Hypercholesterolemia Accelerated
atherosclerosis
• Hypertriglyceridemia
Emptie
• Both tea panchalot
depend relate
HYPERLIPOPROTEINEMIAS
Tendon Xanthomas
• Hypercholesterolemia Accelerated
atherosclerosis
Eruptive Xanthomas
• Hypertriglyceridemia Recurrent Pancreatitis
Lipemia Retinalis
• Both
wᵈfE
follicilar lynerkeration
ERUPTIVE
XANTHOMAS
HYPERLIPOPROTEINEMIAS
Tendon Xanthomas
• Hypercholesterolemia Accelerated
atherosclerosis
Eruptive Xanthomas
• Hypertriglyceridemia Recurrent Pancreatitis
Lipemia Retinalis
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia
• Hypertriglyceridemia
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Type II a
• Hypertriglyceridemia
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Familial
Type II a
Hypercholesterolemia
• Hypertriglyceridemia
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Familial LDL receptor
Type II a
Hypercholesterolemia defect
• Hypertriglyceridemia
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Familial LDL receptor
Type II a
Hypercholesterolemia defect
AUTOSOMAL
• Hypertriglyceridemia DOMINANT
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Familial LDL receptor
Type II a
Hypercholesterolemia defect
AUTOSOMAL
• Hypertriglyceridemia DOMINANT
Type I, IV and V
• Both
HYPERLIPOPROTEINEMIAS
• Hypercholesterolemia Familial LDL receptor
Type II a
Hypercholesterolemia defect
AUTOSOMAL
• Hypertriglyceridemia DOMINANT
Type I, IV and V
• Both
Type IIb, III
TYPE I HYPERLIPOPROTEINEMIA
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
apoca LPL
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
eat
• Apo CII or LPL defect
E
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
• Apo CII or LPL defect
• Hypertriglyceridemia 150cg1dL
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
• Apo CII or LPL defect
• Hypertriglyceridemia
• Recurrent pancreatitis, eruptive xanthomas
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
• Apo CII or LPL defect
• Hypertriglyceridemia
• Recurrent pancreatitis, eruptive xanthomas
• Lipemia retinalis
TYPE I HYPERLIPOPROTEINEMIA
• Familial Hyperchylomicronemia syndrome
• Apo CII or LPL defect
• Hypertriglyceridemia
• Recurrent pancreatitis, eruptive xanthomas
• Lipemia retinalis
• LPL activity is low
TYPE I HYPERLIPOPROTEINEMIA CAPOCH
• Hypertriglyceridemia
• Recurrent pancreatitis, eruptive xanthomas
• Lipemia retinalis
É
• LPL activity is low
• Post heparinised blood sample
LPL apocI
2P after mighty apocII
TYPE III HYPERLIPOPROTEINEMIA
TYPE III HYPERLIPOPROTEINEMIA
• Apo E defect
are
TYPE III HYPERLIPOPROTEINEMIA
• Apo E defect
• REMNANT DISEASE
TYPE III HYPERLIPOPROTEINEMIA
• Apo E defect
• REMNANT DISEASE
• ELEVATION OF BOTH CHOLESTEROL & TGL
TYPE III HYPERLIPOPROTEINEMIA
• Apo E defect
• REMNANT DISEASE
• ELEVATION OF BOTH CHOLESTEROL & TGL
• BROAD BETA DISEASE
TYPE III HYPERLIPOPROTEINEMIA
• Apo E defect
• REMNANT DISEASE
• ELEVATION OF BOTH CHOLESTEROL & TGL
• BROAD BETA DISEASE
• FAMILIAL DYSBETALIPOPROTEINEMIA
LIPOPROTEIN ELECTROPHORESIS
1
LIPOPROTEIN ELECTROPHORESIS
LIPOPROTEIN ELECTROPHORESIS
-
TYPE III HYPERLIPOPROTEINEMIA
- +
LIPOPROTEIN ELECTROPHORESIS
Are
- +
LIPOPROTEIN ELECTROPHORESIS
He
α
- +
LIPOPROTEIN ELECTROPHORESIS
ALPHA BAND /
HDL
- +
LIPOPROTEIN ELECTROPHORESIS
ALPHA BAND /
CHYLOMICRON HDL
- +
LIPOPROTEIN ELECTROPHORESIS LE LE
ALPHA BAND /
LpX
CHYLOMICRON HDL
- +
LIPOPROTEIN ELECTROPHORESIS
LCAT
DEFICIENCY
ALPHA BAND /
LpX HDL
- +
LIPOPROTEIN ELECTROPHORESIS 50
DISCOIDAL
LCAT HDL à
X
DEFICIENCY SPHEROIDAL
x
HDL ALPHA BAND /
LpX HDL
- +
LIPOPROTEIN ELECTROPHORESIS
DISCOIDAL
LCAT HDL à OBSTRUCTVE
DEFICIENCY SPHEROIDAL JAUNDICE
HDL ALPHA BAND
LpX
/ HDL
- +
LIPOPROTEIN ELECTROPHORESIS
ALPHA BAND
LpX / HDL
III
LDL
- +
LIPOPROTEIN ELECTROPHORESIS
ALPHA BAND
LpX / HDL
Palmer reupt
TYPE III HYPERLIPOPROTEINEMIA
TYPE III HYPERLIPOPROTEINEMIA
TYPE III HYPERLIPOPROTEINEMIA
4 Sheerin
PALMAR ERUPTIVE
XANTHOMA palmoni
TYPE III HYPERLIPOPROTEINEMIA
PALMAR ERUPTIVE
XANTHOMA
TYPE III HYPERLIPOPROTEINEMIA
8
ORGANISATION
TYPES OF NITROGENOUS BASES
TYPES OF NITROGENOUS BASES
● Two types
TYPES OF NITROGENOUS BASES
● Two types
● Purines
TYPES OF NITROGENOUS BASES
● Two types
● Purines
● Pyrimidines
TYPES OF NITROGENOUS BASES
● Two types
● Pyrimidines
TYPES OF NITROGENOUS BASES
● Two types
● Purines
● Pyrimidines
TYPES OF NITROGENOUS BASES
● Two types
● Purines
● Pyrimidines C, U, T
TYPES OF NITROGENOUS BASES
● Two types
● Purines
● Pyrimidines C, U, T
1s
Leftridge
NUCLEOSIDE
no
• Base + Ribose or Deoxyribose sugar à Nucleoside + PO4 = NMP
PET
ALL 31
phosEster
NUCLEOSIDE
• Base + Ribose or Deoxyribose sugar à Nucleoside + PO4 = NMP
• NMP + PO4 = NDP
NUCLEOSIDE
• Base + Ribose or Deoxyribose sugar à Nucleoside + PO4 = NMP
• NMP + PO4 = NDP
• NDP + PO4 = NTP
STRUCTURE OF A NUCLEOTIDE
Me
ftp.nglyueeh
POLYNUCELOTIDE FORMATION
ftp.II
31
POLYNUCELOTIDE FORMATION
POLYNUCELOTIDE FORMATION
0 0 0
c
i
CHROMOSOME Hilton Bainprotein
Is Ilyin
J
iIIT
FACTS ABOUT HISTONES
I Ted
08
FACTS ABOUT HISTONES
faddage
of
FACTS ABOUT HISTONES
FF
FACTS ABOUT HISTONES
FACTS ABOUT GENES to
do
Basset
Troubled
42N pyfgffnip.tl 7
fathom
finning.fr
IE iie
FACTS ABOUT GENES
DENATURATION 50
top Intact
1m
y
1m α salt
dualty Forward
TYPES OF DNA
B TYPE: Most common
Rt hardedy boiled
compleman
Cff
I mayer groo
3.44 bp
34 A
20A
feel team
1 mar grome
A TYPE:
Dehydration DNA RNA RNA RNA
Rt hauled loiter
11 tune
bp full
Grooves same dimension
Z TYPE:
ac seek stipe
Left hadedly
of 12 hp gut him
TYPES OF CHROMATIN
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
CHROMATIN
HETEROCHROMATI
EUCHROMATIN
N
Active
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Active
Uncondensed
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Active
Uncondensed
Less densely
stained
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Active Inactive
Uncondensed
Less densely
stained
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Active
Uncondensed Inactive
Less densely condensed
stained
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Active Inactive
Uncondensed condensed
Less densely More densely
stained stained
constitt facultat
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
CONSTITUTIVE
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
8K
CONSTITUTIVE FACULTATIVE
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
Banned
CONSTITUTIVE FACULTATIVE
Always inactive
at e.g., Centromere
& Telomeres
CHROMATIN
EUCHROMATIN HETEROCHROMATIN
CONSTITUTIVE FACULTATIVE
Go
Phase
PHASES OF CELL CYCLE
Go G1
Phase Phase
PHASES OF CELL CYCLE
S Phase
Go G1
Phase Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
M Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
M Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
M Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
M Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
M Phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
Complet
e resting M Phase
phase
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED
CHROMOSOME
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED
CHROMOSOME
PHASES OF CELL CYCLE
S Phase
Go G1 G2
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
PHASES OF CELL CYCLE
Go
S Phase
Go G1 G2
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
PHASES OF CELL CYCLE
REPLICATION
S Phase
Go G1 Timffman G2
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
REPLICATION
PROOFREADIN S Phase
G & REPAIR
Go G1 G2
pound
Phase Phase Phase pearls
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
REPLICATION
PROOFREADIN S Many
Phase
G & REPAIR
PROOFREADING
Go G1 G2
& REPAIR
Phase Phase Phase
e
Complet
e resting
phase to
M Phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
REPLICATION
PROOFREADIN S Phase
G & REPAIR
PROOFREADING
Go G1 G2
& REPAIR
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
INTERPHASE
REPLICATION
PROOFREADIN S Phase
G & REPAIR
PROOFREADING
Go G1 G2
& REPAIR
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
UNCONDENSED
INTERPHASE
CHROMOSOME
REPLICATION
PROOFREADIN S Phase
G & REPAIR
PROOFREADING
Go G1 G2
& REPAIR
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
UNCONDENSED
INTERPHASE
CHROMOSOME
REPLICATION
PROOFREADIN S Phase
G & REPAIR
PROOFREADING
D
Go G1 G2
& REPAIR
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
CONDENSED FORM OF CHROMOSOME
v0
MI not you
manufactured
EfInfo
UNCONDENSATION OF CHROMOSOME
inD E A B
D FX
UNCONDENSED
INTERPHASE
CHROMOSOME
REPLICATION
PROOFREADIN S Phase
G & REPAIR
PROOFREADING
Go G1 G2
& REPAIR
Phase Phase Phase
Complet
e resting M Phase
phase
CONDENSED CONDENSED
CHROMOSOME CHROMOSOME
MCQs
1. All of the following are purine bases except
a. Adenine
b. Uric acid
c. Hypoxanthine
d. Uracil.
1. All of the following are purine bases except
a. Adenine
b. Uric acid
c. Hypoxanthine
d. Uracil.
2. The linkage present in a nucleoside is
a. α N glycosidic linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. Acid anhydride linkage
2. The linkage present in a nucleoside is
a. α N glycosidic linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. Acid anhydride linkage
3. The linkage present in a monophosphate nucleotide
is
a. α N glycosidic linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. Acid anhydride linkage
3. The linkage present in a monophosphate nucleotide
is
a. α N glycosidic linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. Acid anhydride linkage
5. The linkage present between individual nucleotides
in a polynucleotide chain is
a. 3’5’ phosphodiester linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. 5’3’ phosphodiester linkage
5. The linkage present between individual nucleotides
in a polynucleotide chain is
a. 3’5’ phosphodiester linkage
b. β N glycosidic linkage
c. Phosphoester linkage
d. 5’3’ phosphodiester linkage
tolerance
Ifs
1. Regarding DNA structure true is, K
a. The double helical structure is stabilised by
covalent bonds F
b. The individual strands are stabilized by 5’3’
phosphodiester linkage P
c. The individual strands are stabilized by 3’5’
phosphodiester linkage
Your
d. The term 5’ end indicates that the 5’ end is
linked to kinetochore. centromere
KINETOCHORE
1. Regarding DNA structure true is,
a. The double helical structure is stabilised by
covalent bonds
b. The individual strands are stabilized by 5’3’
phosphodiester linkage
c. The individual strands are stabilized by 3’5’
phosphodiester linkage
d. The term 5’ end indicates that the 5’ end is
linked to kinetochore.
1. Regarding DNA structure true is,
a. The double helical structure is stabilised by
covalent bonds
b. The individual strands are stabilized by 5’3’
phosphodiester linkage
c. The individual strands are stabilized by 3’5’
phosphodiester linkage
d. The term 5’ end indicates that the 5’ end is
linked to kinetochore.
• The histone that is not present is a nucleosome is
a. H1
b. H2A
c. H2B
d. H3
• The histone that is not present is a nucleosome is
a. H1
b. H2A
c. H2B
d. H3
12. Barr body is an example of
a. Euchromatin
b. Constitutive heteochromatin
c. Facultative heterochromatin
d. Hypersensitive heterochromatin
12. Barr body is an example of
a. Euchromatin
b. Constitutive heteochromatin
c. Facultative heterochromatin
d. Hypersensitive heterochromatin
2. The most common form of DNA is,
a. B DNA
b. Z DNA
c. A DNA
d. E DNA
2. The most common form of DNA is,
a. B DNA
b. Z DNA
c. A DNA
d. E DNA
3. The features of B DNA include, all except
a. It is a right handed helix
b. One full turn of DNA has 10 nuceotides and measure
34A0, width 20A0
c. Major groove is equal to minor groove in terms of
width
d. It is the form that is present under physiological
conditions.
3. The features of B DNA include, all except
a. It is a right handed helix
b. One full turn of DNA has 10 nuceotides and measure
34A0, width 20A0
c. Major groove is equal to minor groove in terms of
width
d. It is the form that is present under physiological
conditions.
4. The left handed helix is seen in,
a. B DNA
b. Z DNA
c. A DNA
d. E DNA
4. The left handed helix is seen in,
a. B DNA
b. Z DNA
c. A DNA
d. E DNA
• Denaturation of DNA is done by all except,
a. Increasing the temperature N
b. Increasing the salt concentration
c. Decreasing the salt concentration
d. Formamide
• Denaturation of DNA is done by all except,
a. Increasing the temperature
b. Increasing the salt concentration
c. Decreasing the salt concentration
d. Formamide
6. Which of the following is true?
a. To break AT bonds, high Tm is required
b. To break GC bonds, low Tm is required
c. To break AT bonds, low Tm is required
d. AT bonds and GC bonds need the same Tm
INICET NOV
2022
6. Which of the following is true?
a. To break AT bonds, high Tm is required
b. To break GC bonds, low Tm is required
c. To break AT bonds, low Tm is required
d. AT bonds and GC bonds need the same Tm
INICET NOV
2022
• Replication occurs in
a.Go Phase
b.G1 Phase
c.S Phase
d.M phase
• Replication occurs in
a.Go Phase
b.G1 Phase
c.S Phase
d.M phase
• The phase in which chromosomes are uncondensed is
a.Go Phase
b.G1 Phase
c.Metaphase
d.M phase
• The phase in which chromosomes are uncondensed is
a.Go Phase
b.G1 Phase
c.Metaphase
d.M phase
FACTS ABOUT TYPES OF HUMAN GENOMIC SEQUENCES
n of bp 3.3 109
ggengy.me 2ggyp
size of mrna 2000nA
8th May
I MIellaneus
Traiposon Jumpy get
Gene
Modent repute
IT 28 540
1001050 Ea.io
DNA
Enons Two 7 HRS
LINES SINES SSR
6 tomb 10082002ps
1
⑪
⑥
STEPS INVOLVED IN PATERNAL DISPUTE CASES
STEPS INVOLVED IN PATERNAL DISPUTE CASES
• Blood sample from mother, child and the suspected father
STEPS INVOLVED IN PATERNAL DISPUTE CASES
• Blood sample from mother, child and the suspected father
• DNA is extracted
IMSR 5 loci
STEPS INVOLVED IN PATERNAL DISPUTE CASES
• Blood sample from mother, child and the suspected father
• DNA is extracted
• 5 MSR at 5 loci each at 227903141
STEPS INVOLVED IN PATERNAL DISPUTE CASES
• Blood sample from mother, child and the suspected father
• DNA is extracted
• 5 MSR at 5 loci each
CHILD’S DNA – 8/8
STEPS INVOLVED IN PATERNAL DISPUTE CASES
• Blood sample from mother, child and the suspected father
• DNA is extracted
• 5 MSR at 5 loci each
CHILD’S DNA – 8/8
w w
0
DNA POLYMERASES
DNA POLYMERASES
• TEMPLATE STRAND
DNA POLYMERASES
• TEMPLATE STRAND
DNA POLYMERASES
• TEMPLATE STRAND
5’3’ POLYMERASE
ACTIVITY
5’ 3’
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
PRIMER
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
PRIMER dNTP
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
dNMP
PRIMER dNTP
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
dNMP
3’5’PDE
PRIMER dNTP
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’ 3’
dNMP
3’5’PDE
e
DNA POLYMERASES
• TEMPLATE STRAND
3’ 5’
5’3’ POLYMERASE
ACTIVITY
5’
dNMP 04113’
3’5’PDE
5’3’ exonuclease
activity
Ori
Ori
A-T
RICH i
e
Ori Ori
BP
A-T
RICH
Ori Ori
BP
A-T
RICH
REPLICATION
Ori Ori centre
BUBBLE
BP
A-T
RICH
STEPS OF REPLICATION
this pmi
goggaine
hagggshand
to
STEPS OF REPLICATION
STEPS OF REPLICATION
FUNCTIONS OF PROKARYOTIC DNA POLYMERASES
S.No DNA POLYMERASE FUNCTIONS
2 DNA Polymerase II
laggi stand eyatter
PR repair
3 DNA polymerase III
Leadig shard synhery Okazaki
fragments
FUNCTIONS OF PROKARYOTIC DNA POLYMERASES
S.No DNA POLYMERASE FUNCTIONS
1 DNA Polymerase I
2 DNA Polymerase II
1 Smaller Larger
2
DIFFERENCES BETWEEN PROKARYOTIC & EUKARYOTIC GENOME
1 Smaller Larger
1 Smaller Larger
Multiple Ori s
1 Smaller Larger
Multiple Ori s
m
we
2 deep Dope
RNA
v
E
b.Bidirectional
c.Non conservation
d.Unidirectional
2. DNA polymerase requires all except,
a. RNA primer Yes
b. 3’ to 5’ strand to act as a templateYes
c. d NTP Yes
d. 5’ to 3’ strand as a template
2. DNA polymerase requires all except,
a. RNA primer
b. 3’ to 5’ strand to act as a template
c. d NTP
d. 5’ to 3’ strand as a template
3. Replication fork includes all except,
a. Helicase
b. Primase
c. DNA polymerase III
d. DNA polymerase I.
3. Replication fork includes all except,
a. Helicase
b. Primase
c. DNA polymerase III
d. DNA polymerase I.
4. Replication along lagging strand, true is,
a. Polymerase I synthesizes along 3’ to 5’ direction
b. Helicase and primase join to form primosome and moves
along the lagging strand
c. Okazaki fragments are joined together by DNA helicase
d. DNA polymerase III removes RNA primer
4. Replication along lagging strand, true is,
a. Polymerase I synthesizes along 3’ to 5’ direction
b. Helicase and primase join to form primosome and moves
along the lagging strand
c. Okazaki fragments are joined together by DNA helicase
d. DNA polymerase III removes RNA primer
5. Function of DNA polymerase δ except,
a. Gap filling
b. Leading strand synthesis
c. Okazaki fragments synthesis
d. RNA primase
5. Function of DNA polymerase δ except,
a. Gap filling
b. Leading strand synthesis
c. Okazaki fragments synthesis
d. RNA primase
6. DNA polymerase with repair mechanism is:
a. DNA polymerase I
b. DNA polymerase II
c. DNA polymerase III
β
d. DNA polymerase α
6. DNA polymerase with repair mechanism is:
a. DNA polymerase I
b. DNA polymerase II
c. DNA polymerase III
d. DNA polymerase α
7. True about telomerase are all except:
a. They are present at the ends of eukaryotic chromosome Yes
b. Increased telomerase activity is associated with malignancy
c. DNA dependent RNA polymerase Yes
Ms
d. DNA polymerase
7. True about telomerase are all except:
a. They are present at the ends of eukaryotic chromosome
b. Increased telomerase activity is associated with malignancy
c. DNA dependent RNA polymerase
d. DNA polymerase
ERRORS OF REPLICATION
Bare Excuri
DNA ERRORS
DNA ERRORS
• Base excision error
2
EE
DNA ERRORS
• Base excision error
• Mismatch error
DNA ERRORS
• Base excision error
• Mismatch error
• Pyr Pyr Dimerisation
DNA ERRORS
• Base excision error
• Mismatch error
• Pyr Pyr Dimerisation
• Ds DNA break
DNA ERRORS
• Base excision error – most common
• Mismatch error 11
It
• Ds DNA break repair
Cockayne syndrome
FOUR REPAIR MECHANISM
• Base Excision Repair
• Mismatch repair
• Nucleotide Excision repair
• Ds DNA break repair
DS DNA BREAK
• Ionising radiation
DS DNA BREAK
• Ionising radiation
KU HELICASE
NHEJ - Ku HELICASE
KU HELICASE
NHEJ - Ku HELICASE
KU HELICASE
0
NHEJ - Ku HELICASE
KU HELICASE
NHEJ - Ku HELICASE
KU HELICASE
NHEJ - Ku HELICASE
KU HELICASE
•B
•F
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
•B
•F
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
• BLOOM’S SYNDROME
•F
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
• BLOOM’S SYNDROME
• FANCONI’S ANEMIA
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
NHEJ
• BLOOM’S SYNDROME
• FANCONI’S ANEMIA
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
NHEJ SCID
• BLOOM’S SYNDROME
• FANCONI’S ANEMIA
DEFECTS OF ds DNA BREAK REPAIR
• ATAXIA TELANGIECTASIA
NHEJ SCID
• BLOOM’S SYNDROME
• FANCONI’S ANEMIA
• FANCONI’S ANEMIA
HDR
• HBOC (Human Breast and Ovarian Cancer)
• The most common error in a DNA is
a.Base Excision
b.Pyrimidine dimer
c.Mismatch
d.Ds DNA break
• The most common error in a DNA is
a.Base Excision
b.Pyrimidine dimer
c.Mismatch
d.Ds DNA break
• Mismatch repair defect causes
a.HNPCC
b.Xeroderma pigmentosa
c.Fanconi’s anemia
d.Ataxia Telangiectasia
• Mismatch repair defect causes
a.HNPCC
b.Xeroderma pigmentosa
c.Fanconi’s anemia
d.Ataxia Telangiectasia
MUST KNOW MCQ
• UV light damage to the DNA leads to:
• mRNA
TYPES OF RNA
• rRNA
• mRNA
• tRNA
TYPES OF RNA
• rRNA
• mRNA
• tRNA
• sRNA
rRNA TIANA fos
f
tRNA yes 069
Ly ribozyme peptidylhayear
rRNA
GENE, TRANSCRIPTION, MODIFICATIONS
T
hhienemrva.rs prokaryotic
spley
No A tail addition
poly
7
RNA EDITING
APOBUS no
VLDL
Ayloneion
Hepatocytes
JUN TEAM
cytidmdiamiia
tsfust.mg mafioso
Urdie
Apo B48
Eta
C T
Apo B48
Apo B48
RNA EDITING
• Edit some of the nucleotide sequences of the fully formed mRNA in
specific tissues
RNA EDITING
• Edit some of the nucleotide sequences of the fully formed mRNA in
specific tissues
2 AA
50to1wR
AA
tRNA - STRUCTURE
3 II 51
Dawn
Ignition
aatrussyntretar .in Anticodon arm
tRNA - STRUCTURE glyFRNAsyntheter
pogey
fifthly
tRNA - STRUCTURE
sRNA
SnRNA
SiRNA
snRNA 6 lynes
Steinloop shuckier
v www
exckphie
fe
snRNA
• Six types – U1 to U7 except U3
• All except U7 help in splicing
• U7 helps in stem loop structure attachment
siRNA gene expression
FIT
t iE
3
siRNA
• Mediates interference of gene expression at the translation level
• One of the mechanisms of regulation of gene expression
• Causes gene knock down
MCQs
• m RNA is characterized by, all except
a. The nucleotide bases of mRNA are grouped in three to
form a codon.
b. Mature mRNA has a 7-methyl guanosine cap and poly A
tail
c. hn RNA is the form that is present in cytoplasm
d. hn RNA has introns in it
• m RNA is characterized by, all except
a. The nucleotide bases of mRNA are grouped in three to
form a codon.
b. Mature mRNA has a 7-methyl guanosine cap and poly A
tail
c. hn RNA is the form that is present in cytoplasm
d. hn RNA has introns in it
• Fidelity of gene is conferred by,
a. r RNA
b. m RNA
c. t RNA
d. Sn RNA
• Fidelity of gene is conferred by,
a. r RNA
b. m RNA
c. t RNA
d. Sn RNA
• Fidelity of gene is conferred by,
a. r RNA
b. aatRNA synthetase
c. t RNA
d. Sn RNA
• Fidelity of gene is conferred by,
a. r RNA
b. aatRNA synthetase
c. t RNA
d. Sn RNA
• The amino acid is attached to which arm
of tRNA
a. D arm
b. T ψ C arm
c. Acceptor arm
d. Anticodon arm
• The amino acid is attached to which arm
of tRNA
a. D arm
b. T ψ C arm
c. Acceptor arm
d. Anticodon arm
• Which of the following is the functions of D arm
of tRNA
a. Ribosomal attachment
b. Attachment of aatRNA synthetase
c. Aminoacid attachment
d. Anticodon arm
• Which of the following is the functions of D arm
of tRNA
a. Ribosomal attachment
b. Attachment of aatRNA synthetase
c. Aminoacid attachment
d. Anticodon arm
• The function of Sn RNA is
a. Formation of hn RNA
b. Formation of t RNA
c. Splicing
d. Formation of ribosomes.
• The function of Sn RNA is
a. Formation of hn RNA
b. Formation of t RNA
c. Splicing
d. Formation of ribosomes.
• siRNA causes
a. Gene knock down
b. Gene knock in
c. Gene Knock out
d. Gene conversion
• siRNA causes
a. Gene knock down
b. Gene knock in
c. Gene Knock out
d. Gene conversion
18. apo B 48 formation is an example of
a. Truncation of protein
b. RNA editing
c. Rearrangement of glycosidic bond
d. Modification by methylation
18. apo B 48 formation is an example of
a. Truncation of protein
b. RNA editing
c. Rearrangement of glycosidic bond
d. Modification by methylation
TRANSCRIPTION
REPLICATION AND TRANSCRIPTION
TEMPLATE STRAND IS PROVIDED
CODING STRAND IS PROVIDED
GENE IS PROVIDED
DNA & RNA POLYMERASES
DNA & RNA POLYMERASES
NUMBERING NUCLEOTIDES IN CODING STRAND
Band pometer Regulateentry
TRANSCRIPTION CONTROL REGIONS
Agulate
E 3
IE
5
a
TRANSCRIPTION CONTROL REGIONS
PROMOTORS REGULATORS
Indidrepe
Enhancer
TRANSCRIPTION CONTROL REGIONS
PROMOTORS REGULATORS
fidely frequency
INDUCERS
REPRESSORS
TRANSCRIPTION CONTROL REGIONS
PROMOTORS REGULATORS
DPE
TATABO
Inr
18in
0
FIDELITY FREQUENCY
I RNA 9C CAAT
Polymerase
DIFFERENCES BETWEEN PROMOTOR AND
REGULATORS
S.No PROMOTOR REGULATOR
Baral Rgulates
1
Space seq TA Any
2
3
pattern
Onenteth
Meiji
4
hereapogie
5
3 ATCAT
a. 5’GCAATAAATGAT3’
b. 5’GCAAUAAAUGAU3’
VAGUA
c. 5’UAGUAAAUAACG3’
d. 5’CGUUAUUUACUA3’
a. 5’GCAATAAATGAT3’
b. 5’GCAAUAAAUGAU3’
c. 5’UAGUAAAUAACG3’
d. 5’CGUUAUUUACUA3’
2
c. Complete removal of introns
d. RNA editing
3 UTR
d D
UTR
15. Posttranscriptional modification of mRNA include all except
a.7- methyl guanosine capping
b. Poly A tail
c. Complete removal of introns
d. RNA editing
44
33
GENETIC CODE
4 64
Total no g coden 64
stop codons
Codas AA
PROPERTIES OF GENETIC CODE
PROPERTIES OF GENETIC CODE
• 61 codons
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids
• Degenerate
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids
• Degenerate
• Degenerate HE
• Unambiguous
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids
11404507139
C
• Degenerate
• Unambiguous
• Non overlapping
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids
• Degenerate
• Non overlapping
• Not punctuated
PROPERTIES OF GENETIC CODE
• 61 codons code for 20 aminoacids 0910 stopcodon
• Degenerate
• Unambiguous
try
• Non overlapping
AAA AGG Ay
• Not punctuated
I
• Universal Stepcoder
WOBBLE PHENOMENON
WOBBLE PHENOMENON
• 5’ – GGG – GGC – GGA – GGU – 3’
31
58
47
70
I m t ane g rrna
WOBBLE PHENOMENON
• Reduced stringency when the 3rd nucleotide pair is formed between
codon and anticodon
WOBBLE PHENOMENON
• Reduced stringency when the 3rd nucleotide pair is formed between
codon and anticodon
AA seg
fn of protein
TYPES OF MUTATION
• Nucleotide Sequences
TYPES OF MUTATION
• Nucleotide Sequences
• Aminoacid sequences
TYPES OF MUTATION
• Nucleotide Sequences
• Aminoacid sequences
• Function of protein
TYPES OF MUTATION - Nucleotide Sequences
t FS Mulate
point meetate
Substitution
tf
IT Dolet Inverter
Transiter transverse
puts pu puts pyr
py Pyo
TYPES OF MUTATION - Aminoacid Sequences
Line
17 Noneme
AA Chaged C A
AAreq c Al stopcoden
C A C2 Az
cat
TYPES OF MUTATION – Function of protein
Tannty
Accepted
Ntieg
aceepletic
immedecht
Ntrey AAreqx
UB AAreq fnqprote
67MAA svalue.th Noli
Life
Hb Milwaukee 4b
Hb BristolApe
ub Sydney
6ᵗʰ coden Glu
Val
MCQs
s
2. No of possible codons
a. 64
b. 61
c. 20
d. 31
2. No of possible codons
a. 64
b. 61
c. 20
d. 31
3. No of codons which code for an aminoacid
a. 64
b. 61
c. 20
d. 31
3. No of codons which code for an aminoacid
a. 64
b. 61
c. 20
d. 31
4. Codon consists of:
a. 3 base pairs
b. 2 base pairs
c. 5 base pairs
d. 3 nucleotides
4. Codon consists of:
a. 3 base pairs
b. 2 base pairs
c. 5 base pairs
d. 3 nucleotides
4. Stop codon:
a. UAG
b. UCA
c. UAC
d. AUG
4. Stop codon:
a. UAG
b. UCA
c. UAC
d. AUG
5. All the following are properties of genetic code except,
a. Degenerate
b. Ambiguous
c. Nonoverlapping
d. Universal
5. All the following are properties of genetic code except,
a. Degenerate
b. Ambiguous
c. Nonoverlapping
d. Universal
5. The amino acid which does not follow degeneracy of codon is,
a. Glycine
b. Glutamine
c. Tryptophan
d. Tyrosine
5. The amino acid which does not follow degeneracy of codon is,
a. Glycine
b. Glutamine
c. Tryptophan
d. Tyrosine
6. Wobble phenomenon explains which of the following,
a. Degeneracy
b. Unambiguity
c. Ambiguity
d. Punctuation
6. Wobble phenomenon explains which of the following,
a. Degeneracy
b. Unambiguity
c. Ambiguity
d. Punctuation
CASE BASED MCQs
• A 45 year old male is detected to have fasting and postprandial
hyperglycemia in the diagnostic range of diabetes. To understand
his long term glycemic control, he is asked to estimate his HbA1C.
Chromatogram detects an abnormal Hemoglobin peak,
corresponding to Hb Bristol. His oxygen carrying capacity is
normal. Hb Bristol is an example of
a. Silent Mutation
b. Acceptable mutation
c. Partially acceptable mutation
d. Non sense mutation
• A 45 year old male is detected to have fasting and postprandial
hyperglycemia in the diagnostic range of diabetes. To understand
his long term glycemic control, he is asked to estimate his HbA1C.
Chromatogram detects an abnormal Hemoglobin peak,
corresponding to Hb Bristol. His oxygen carrying capacity is
normal. Hb Bristol is an example of
a. Silent Mutation
b. Acceptable mutation
c. Partially acceptable mutation
d. Non sense mutation
STEPS OF TRANSLATION
INITIATION
PIF
INITIATION
• eIF
INITIATION
• eIF
2
Meet
0
• eIF2C
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
INITIATION
• eIF
• eIF2C
• eIF3 & 1A
INITIATION
• eIF
• eIF2C
• eIF3 & 1A
• eIF 4G/4A
INITIATION
• eIF
• eIF2C
• eIF3 & 1A
• eIF 4G/4A
• eIF4A/4B
INITIATION
• eIF
O
• eIF2C
• eIF3 & 1A
• eIF 4G/4A
• eIF4A/4B
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
• eIF3 & 1A
• eIF 4G/4A
• eIF4A/4B
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
• eIF 4G/4A
• eIF4A/4B
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
• eIF4A/4B
AB
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
xo0m n
PA
819A HAHB
etgcʰTP 4914A
43s
3
5 Bet PU
TELEEL
Meet
STEPS OF TRANSLATION
2
Q HÉ
s tha
o
Bet
STEPS OF TRANSLATION 3
m
000
EFIA9
f
P
IIIIIIniffing paradigetranger
EF.IE
RI9TP
4 34 1 4 1
STEPS OF TRANSLATION
t
INITIATION
• eIF
• eIF2C
• eIF3 & 1A
• eIF 4G/4A
• eIF4A/4B
• eIF5
INITIATION
• eIF
tRNA Methionine complex
• eIF2C formation
1
2
3
TOTAL
ENERGETICS OF TRANSLATION
S.No STEP Number of ATPs
1 Activation of aminoacid 2
2 Attachment of aatRNA to A site 1
3 Translocation step 1
TOTAL 4
DIFFERENCES BETWEEN imet tRNA & OTHER tRNAs
S.No imet tRNA aa tRNA
1
2
3
DIFFERENCES BETWEEN imet tRNA & OTHER tRNAs
S.No imet tRNA aa tRNA
1
Freezes into
2
Aminoglycoside Poynne
3 Tetracycline EFIA aatra A
chloramphenicol prokaryote
4 pentatyehayarae
5 Cycloheren
Ruin Eukaryote
Mandide clindamycin Translocation prokaryote
6
Eukaryotes Tranlocution
7
Tffonger aatra
analyn
INHIBITORS LIST
S.No INHIBITOR MECHANISM OF ACTION